Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

181 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911).
Bolla M, van Poppel H, Collette L, van Cangh P, Vekemans K, Da Pozzo L, de Reijke TM, Verbaeys A, Bosset JF, van Velthoven R, Maréchal JM, Scalliet P, Haustermans K, Piérart M; European Organization for Research and Treatment of Cancer. Bolla M, et al. Among authors: van poppel h, van cangh p, van velthoven r. Lancet. 2005 Aug 13-19;366(9485):572-8. doi: 10.1016/S0140-6736(05)67101-2. Lancet. 2005. PMID: 16099293 Clinical Trial.
Patients at high risk of progression after radical prostatectomy: do they all benefit from immediate post-operative irradiation? (EORTC trial 22911).
Collette L, van Poppel H, Bolla M, van Cangh P, Vekemans K, Da Pozzo L, de Reijke TM, Verbaeys A, Bosset JF, Piérart M; European Organisation for Research and Treatment of Cancer (EORTC) Radiotherapy and Genito-urinary Groups. Collette L, et al. Among authors: van poppel h, van cangh p. Eur J Cancer. 2005 Nov;41(17):2662-72. doi: 10.1016/j.ejca.2005.06.024. Epub 2005 Oct 11. Eur J Cancer. 2005. PMID: 16223581 Clinical Trial.
Impact of pathology review of stage and margin status of radical prostatectomy specimens (EORTC trial 22911).
van der Kwast TH, Collette L, Van Poppel H, Van Cangh P, Vekemans K, DaPozzo L, Bosset JF, Kurth KH, Schröder FH, Bolla M; European Organisation for Research and Treatment of Cancer Radiotherapy and Genito-Urinary Cancer Groups. van der Kwast TH, et al. Among authors: van poppel h, van cangh p. Virchows Arch. 2006 Oct;449(4):428-34. doi: 10.1007/s00428-006-0254-x. Epub 2006 Aug 29. Virchows Arch. 2006. PMID: 16941153 Clinical Trial.
Retrospective analysis of results of p(65)+Be neutron therapy for treatment of prostate adenocarcinoma at the cyclotron of Louvain-la-Leuve. Part II: Side effects and their influence on quality of life measured with QLQ-C30 of EORTC.
Scalliet PG, Remouchamps V, Curran D, Ledent G, Wambersie A, Richard F, van Cangh P. Scalliet PG, et al. Among authors: van cangh p. Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1549-61. doi: 10.1016/j.ijrobp.2003.09.001. Int J Radiat Oncol Biol Phys. 2004. PMID: 15050336 Review.
Stratification of high-risk prostate cancer into prognostic categories: a European multi-institutional study.
Joniau S, Briganti A, Gontero P, Gandaglia G, Tosco L, Fieuws S, Tombal B, Marchioro G, Walz J, Kneitz B, Bader P, Frohneberg D, Tizzani A, Graefen M, van Cangh P, Karnes RJ, Montorsi F, Van Poppel H, Spahn M; European Multicenter Prostate Cancer Clinical and Translational Research Group (EMPaCT). Joniau S, et al. Among authors: van cangh p. Eur Urol. 2015 Jan;67(1):157-164. doi: 10.1016/j.eururo.2014.01.020. Epub 2014 Jan 25. Eur Urol. 2015. PMID: 24486307
Pretreatment tables predicting pathologic stage of locally advanced prostate cancer.
Joniau S, Spahn M, Briganti A, Gandaglia G, Tombal B, Tosco L, Marchioro G, Hsu CY, Walz J, Kneitz B, Bader P, Frohneberg D, Tizzani A, Graefen M, van Cangh P, Karnes RJ, Montorsi F, van Poppel H, Gontero P; European Multicenter Prostate Cancer Clinical and Translational Research Group (EMPaCT). Joniau S, et al. Among authors: van cangh p. Eur Urol. 2015 Feb;67(2):319-25. doi: 10.1016/j.eururo.2014.03.013. Epub 2014 Mar 21. Eur Urol. 2015. PMID: 24684960
The role of adjuvant hormonal treatment after surgery for localized high-risk prostate cancer: results of a matched multiinstitutional analysis.
Schubert M, Joniau S, Gontero P, Kneitz S, Scholz CJ, Kneitz B, Briganti A, Karnes RJ, Tombal B, Walz J, Hsu CY, Marchioro G, Bader P, Bangma C, Frohneberg D, Graefen M, Schröder F, van Cangh P, van Poppel H, Spahn M. Schubert M, et al. Among authors: van cangh p. Adv Urol. 2012;2012:612707. doi: 10.1155/2012/612707. Epub 2012 Jan 31. Adv Urol. 2012. PMID: 22400018 Free PMC article.
181 results